Should we look for dry eye on every patient? I get this question with some frequency. I admit I find it perplexing. I am reminded of a practitioner asking me several years ago if I did biomicroscopy on every patient. Well, of course! Do I look for dry eye disease on every patient? The answer is a re
European researchers have recommended patients with eyelid eczema be referred to an ophthalmologist before being prescribed dupilumab after finding the treatment likely caused or aggravated dry eye disease (DED) in a French study.
In 2019, young gamers seemed like a good proxy to study the association between extended screen time, blinking and dry eye. Armageddon, New Zealand’s largest gaming convention, provided an ideal opportunity for this. With the generous support of the organisers, optometry students donned eye-catching
The most severe forms of chronic dry eye disease (DED) are often caused by underlying immune-mediated diseases. These can be visually debilitating in some cases and treatment may be challenging. Dry eye disease may result directly or indirectly from these conditions, some of which are summarised bel
As the major cause of evaporative dry eye disease¹, meibomian gland dysfunction (MGD) requires careful assessment in the clinical setting. Morphological characteristics of meibomian glands are evaluated by meibography. This technique yields information on MG loss by observing the glands under infra-
With apologies to William Shakespeare for the title, this was indeed the question addressed in our recent literature review1. With increasing availability and focus on preservative-free drops, eye care practitioners have been left wondering if preserved artificial tears continue to have a place in t
A recently awarded Health Research Council (HRC) project grant will investigate a novel eye drop that tackles the vicious circle of dry eye disease (DED), one of the most common, yet undertreated, chronic ocular surface conditions.
In a new study, Italian scientists have found cord blood to be superior to adult blood serum eye drops for treating severe dry eye disease (DED), resistant to conventional therapies.
Novartis has shelved Xiidra in Europe after the European Medicines Agency (EMA) said its effectiveness in treating dry eye disease (DED) had not been demonstrated effectively.
Following the surprising findings from the Dry Eye Assessment and Management (DREAM) Research Group study in 2018, which concluded that omega-3 was no better than olive oil for managing moderate to severe dry eye disease (DED), a Cochrane Systematic Review suggests there might still be a role for th
Dry eye disease is a common ocular surface disorder, resulting in one of the most frequently encountered complaints in ophthalmic practice. Whilst the disease is complex and multifactorial, inflammation is a common denominator in DED, which in turn causes further damage to the corneal epithelium and
Blepharitis is one of the most common ophthalmic conditions, characterised by chronic inflammation of the eyelid tissues and affecting the eyelashes, meibomian glands and ocular surface. Causative and